公司概覽
業務類別 Biotechnology
業務概覽 Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding ofcancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor,is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.
公司地址 245 First Street, 18th Floor, Cambridge, MA, USA, 02142
電話號碼 +1 617 252-0848
傳真號碼 --
公司網頁 https://www.blackdiamondtherapeutics.com
員工數量 21
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Brent Hatzis-Schoch, Esq. Chief Operating Officer and General Counsel 美元 511.00K 29/04/2026
Dr. Mark A. Velleca, M.D.,PhD Chairman of the Board, President and Chief Executive Officer 美元 667.40K 29/04/2026
Dr. Elizabeth Buck, PhD Chief Scientific Officer -- 29/04/2026
Ms. Melanie Morrison Chief Development Officer -- 29/04/2026
Ms. Erika Jones Senior Vice President, Finance, Principal Financial Officer and Principal Accounting Officer -- 29/04/2026
Dr. Sergey Yurasov, M.D. Chief Medical Officer 美元 525.60K 29/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. Kapil Dhingra, M.B.B.S. Independent Director 29/04/2026
Dr. Garry E. Menzel, PhD Independent Director 29/04/2026
Dr. Ali Behbahani, M.B.A.,M.D. Independent Director 29/04/2026
Dr. Samarth Kulkarni, PhD Lead Independent Director 29/04/2026
Dr. Mark A. Velleca, M.D.,PhD Chairman of the Board, President and Chief Executive Officer 29/04/2026
Dr. Prakash Raman, PhD Independent Director 29/04/2026
Dr. Shannon Campbell, PhD Independent Director 29/04/2026
 
所屬ETF (更新日期: 02/05/2026 03:52)
代號 名稱 佔比% 持有日期
FESMFidelity Enhanced Small Cap ETF0.86%29/04/2026
IBBiShares Biotechnology ETF0.60%29/04/2026
BSVOEA Bridgeway Omni Small-Cap Value ETF0.41%29/04/2026
SMLFiShares U.S. Small-Cap Eq Fac ETF0.38%29/04/2026
DFASDimensional US Small Cap ETF0.33%29/04/2026
DFSVDimensional US Small Cap Value ETF0.26%29/04/2026
IWCiShares Micro-Cap ETF0.21%29/04/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.18%29/04/2026
DFATDimensional US Targeted Value ETF0.16%29/04/2026
EESWisdomTree US SmallCap Earnings ETF0.15%28/04/2026
AVSCAvantis US Small Cap Equity ETF0.13%29/04/2026
DFACDimensional US Core Equity 2 ETF0.12%29/04/2026
SQLVRoyce Quant Small-Cap Quality Value ETF0.03%28/04/2026
TMEDT. Rowe Price Health Care ETF0.03%29/04/2026
AVUVAvantis US Small Cap Value ETF0.02%29/04/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%29/04/2026
BIBProShares Ultra Nasdaq Biotechnology0.004%29/04/2026
FEACFidelity Enhanced U.S. All-Cap Eq ETF0.004%29/04/2026
DFAUDimensional US Core Equity Market ETF0.002%29/04/2026
BMEDiShares Health Innovation Active ETF<0.000001%26/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.